Stepped care for panic disorder [Stepped care voor paniekstoornis]

ISRCTN ISRCTN36376369
DOI https://doi.org/10.1186/ISRCTN36376369
Secondary identifying numbers 100003034
Submission date
04/09/2012
Registration date
09/10/2012
Last edited
18/11/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims:
Panic disorder is a severe mental disease where patients experience (unexpected) frightful panic attacks. Most patients try to avoid these attacks by developing avoidance behaviour, e.g. they avoid crowded places. Panic disorder is also a burden for society as medical and social costs are high. Panic disorder treatment guidelines suggest cognitive behaviour therapy (CBT) or treatment with drugs, although CBT has known, longer lasting effects. Normally, CBT takes 10-12 weekly sessions, but CBT is not always easy available and waiting lists are long. Therefore, shorter and cheaper programs, such as guided self-help or internet based treatments have been tested and been successful in the treatment of panic disorder.
This study's goal is to examine whether a short program of guided self-help for panic disorder is beneficial, and only followed by more intensive treatment when necessary

Who can participate?
Patients with a panic disorder with or without agoraphobia. Either men or women, aged between 18-70 years.

What does the study involve?
130 patients (across different treatment centres) will be randomly allocated to one of two treatment conditions:
1. A brief CBT intervention (guided self-help) of 10 weeks followed by CBT (13 sessions) only when necessary
2. Treatment as usual according to the (NICE) guidelines

What are the possible benefits and risks of participating?
There are no negative risks known, since both treatment conditions are well studied and proven to be effective in the treatment for panic disorder. Benefits from enrolling in the study are the monitoring of symptoms and the adjustment of the therapy when necessary. A possible disadvantage is the extra time it may cost to fill in the extra questionnaires.

Where is the study run from?
Overwaal Nijmegen/Lent (part of ProPersona), The Netherlands (Lead Centre)
Hendriks & Roosenboom, private practice Arnhem, The Netherlands
Presenz (part of GgzIngeest), Amsterdam, The Netherlands
HSK Nijmegen en Den Bosch, The Netherlands

When is the study starting and how long is it expected to run for?
The study started in March 2009 and recruitment ended in March 2012. The last follow ups are expected at the end of 2012.

Who is funding the study?
ZONMW, The Netherlands.

Who is the main contact?
Dr Mirjam Kampman
m.kampman@propersona.nl

Contact information

Dr Mirjam Kampman
Scientific

Pro Persona
Pastoor van Laakstraat 48
Lent
6663 CB
Netherlands

Phone +31 (0) 24 8200801
Email m.kampman@propersona.nl

Study information

Study designRandomised trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet [Dutch]
Scientific titlePanic disorder intervention for panic disorder with or without agoraphobia [Stepped care interventie voor patienten met paniekstoornis met en zonder agorafobie]
Study objectives1. Guided self help is an effective first step in the treatment of panic disorder, compared with treatment as usual.
2. In the second step of the stepped care intervention, manualised CBT, panic disorder symptoms will be faster in remission as compared to the treatment as usual.
3. Symptom severity, duration of panic disorder, comorbidity on axis I and II will not predict treatment results of guided self help.
Ethics approval(s)Dutch Medical and Ethical Commission, Nijmegen, The Netherlands, 30 September 2008 ref: NL20312 09108
Health condition(s) or problem(s) studiedMental health, anxiety disorders, panic disorder, treatment studies
InterventionThis study consists of 2 conditions:
1. A first step of guided selfhelp, only when necessary followed by manualised CBT for panic disorder
2. Treatment as usual according to the NICE guidelines

Cognitive behaviour therapy, guided self help, psychopharmacology (in treatment as usual).
Intervention typeOther
Primary outcome measure1. Panic and Agoraphobia Scale (PAS, Bandelow, 1999)
2. Outcome Questionnaire (OQ-45, Lambert and Burlingname, 2001)
Secondary outcome measures1. Agoraphobic Cognition Questionnaire (ACQ, Chambless et al., 1984)
2. Mobility Inventory (MI, Chambless, et al., 1984)
3. Body Sensations Questionnaire (BSQ, Chambless, et al., 1984)
Overall study start date15/03/2009
Completion date01/12/2012

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit70 Years
SexBoth
Target number of participants130
Total final enrolment128
Key inclusion criteria1. Participants have a present, primary diagnosis of panic disorder according to the DSM IV
2. Age between 18-70
3. Patiens give their informed consent
4. Patients are able to read and write the Dutch language
Key exclusion criteria1. A present diagnosis of schizophrenia or another psychotic disorder, according to the DSM-IV
2. Mental retardation, or another organic mental disorder
3. Suicidal ideation
4. Addiction to or abuse of drugs and/or alcohol
5. Another ongoing treatment for panic disorder (allthough the use of an SSRI or benzodiazepines is allowed in the treatment as usual condition)
Date of first enrolment15/03/2009
Date of final enrolment01/03/2012

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Pro Persona
Lent
6663 CB
Netherlands

Sponsor information

ZonMw (Netherlands)
Research organisation

Postbus 93 245
Den Haag
2509 AE
Netherlands

Phone +31 (0) 70 3495111
Email info@zonmw.nl
Website http://www.zonmw.nl
ROR logo "ROR" https://ror.org/01yaj9a77

Funders

Funder type

Research organisation

ZonMw (Netherlands) ref: 100003034
Private sector organisation / Other non-profit organizations
Alternative name(s)
Netherlands Organisation for Health Research and Development
Location
Netherlands
ProPersona (Netherlands)

No information available

Results and Publications

Intention to publish date23/07/2020
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing planNot provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 13/08/2020 18/11/2021 Yes No

Editorial Notes

18/11/2021: Publication reference and total final enrolment added.
23/01/2019: Intention to publish date added.